Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer

被引:69
作者
Kaur, Harsimar B. [1 ]
Guedes, Liana B. [1 ]
Lu, Jiayun [2 ]
Maldonado, Laneisha [1 ]
Reitz, Logan [1 ]
Barber, John R. [2 ]
De Marzo, Angelo M. [1 ,3 ,4 ]
Tosoian, Jeffrey J. [4 ]
Tomlins, Scott A. [5 ,6 ]
Schaeffer, Edward M. [4 ,7 ]
Joshu, Corinne E. [2 ]
Sfanos, Karen S. [1 ,3 ,4 ]
Lotan, Tamara L. [1 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Dept Urol, Sch Med, Baltimore, MD USA
[5] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
[7] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA
关键词
EUROPEAN-AMERICAN MEN; MISMATCH-REPAIR DEFICIENCY; AFRICAN-AMERICAN; PROGNOSTIC-FACTOR; RADICAL PROSTATECTOMY; ANDROGEN RECEPTOR; LUNG-CARCINOMA; PD-1; BLOCKADE; FREE SURVIVAL; LYMPHOCYTES;
D O I
10.1038/s41379-018-0083-x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The inflammatory microenvironment plays an important role in the pathogenesis and progression of tumors and may be associated with somatic genomic alterations. We examined the association of tumor-infiltrating T-cell density with clinical-pathologic variables, tumor molecular subtype, and oncologic outcomes in surgically treated primary prostate cancer occurring in patients of European-American or African-American ancestry. We evaluated 312 primary prostate tumors, enriched for patients with African-American ancestry and high grade disease. Tissue microarrays were immunostained for CD3, CD8, and FOXP3 and were previously immunostained for ERG and PTEN using genetically validated protocols. Image analysis for quantification of T-cell density in tissue microarray tumor spots was performed. Automated quantification of T-cell densities in tumor-containing regions of tissue microarray spots and standard histologic sections were correlated (r = 0.73, p < 0.00001) and there was good agreement between visual and automated T-cell density counts on tissue microarray spots (r = 0.93, p < 0.00001). There was a significant correlation between CD3+, CD8+, and FOXP3+ T-cell densities (p < 0.00001), but these were not associated with most clinical or pathologic variables. Increased T-cell density was significantly associated with ERG positivity (median 309 vs. 188 CD3+ T cells/mm(2); p = 0.0004) and also with PTEN loss (median 317 vs. 192 CD3+ T cells/mm(2) ; p = 0.001) in the combined cohort of matched European-American and African-American ancestry patients. The same association or a similar trend was present in patients of both ancestries when analyzed separately. When the African-American patients from the matched race set were combined with a separate high grade set of African-American cases, there was a weak association of increased FOXP3+ T-cell densities with increased risk of metastasis in multivariable analysis. Though high T-cell density is associated with specific molecular subclasses of prostate cancer, we did not find an association of T-cell density with racial ancestry.
引用
收藏
页码:1539 / 1552
页数:14
相关论文
共 55 条
  • [31] Mutational Landscape of Aggressive Prostate Tumors in African American Men
    Lindquist, Karla J.
    Paris, Pamela L.
    Hoffmann, Thomas J.
    Cardin, Niall J.
    Kazma, Remi
    Mefford, Joel A.
    Simko, Jeffrey P.
    Ngo, Vy
    Chen, Yalei
    Levin, Albert M.
    Chitale, Dhananjay
    Helfand, Brian T.
    Catalona, William J.
    Rybicki, Benjamin A.
    Witte, John S.
    [J]. CANCER RESEARCH, 2016, 76 (07) : 1860 - 1868
  • [32] PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer
    Lotan, Tamara L.
    Wei, Wei
    Morais, Carlos L.
    Hawley, Sarah T.
    Fazli, Ladan
    Hurtado-Coll, Antonio
    Troyer, Dean
    McKenney, Jesse K.
    Simko, Jeffrey
    Carroll, Peter R.
    Gleave, Martin
    Lance, Raymond
    Lin, Daniel W.
    Nelson, Peter S.
    Thompson, Ian M.
    True, Lawrence D.
    Feng, Ziding
    Brooks, James D.
    [J]. EUROPEAN UROLOGY FOCUS, 2016, 2 (02): : 180 - 188
  • [33] TMPRSS2-ERG Gene Fusion Prevalence and Class Are Significantly Different in Prostate Cancer of Caucasian, African-American and Japanese Patients
    Magi-Galluzzi, Cristina
    Tsusuki, Toyonori
    Elson, Paul
    Simmerman, Kelly
    LaFargue, Chris
    Esgueva, Raquel
    Klein, Eric
    Rubin, Mark A.
    Zhou, Ming
    [J]. PROSTATE, 2011, 71 (05) : 489 - 497
  • [34] Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer
    Mani, Ram S.
    Amin, Mohammad A.
    Li, Xiangyi
    Kalyana-Sundaram, Shanker
    Veeneman, Brendan A.
    Wang, Lei
    Ghosh, Aparna
    Aslam, Adam
    Ramanand, Susmita G.
    Rabquer, Bradley J.
    Kimura, Wataru
    Tran, Maxwell
    Cao, Xuhong
    Roychowdhury, Sameek
    Dhanasekaran, Saravana M.
    Palanisamy, Nallasivam
    Sadek, Hesham A.
    Kapur, Payal
    Koch, Alisa E.
    Chinnaiyan, Arul M.
    [J]. CELL REPORTS, 2016, 17 (10): : 2620 - 2631
  • [35] Characterization of Transcriptional Changes in ERG Rearrangement-Positive Prostate Cancer Identifies the Regulation of Metabolic Sensors Such as Neuropeptide Y
    Massoner, Petra
    Kugler, Karl G.
    Unterberger, Karin
    Kuner, Ruprecht
    Mueller, Laurin A. J.
    Faelth, Maria
    Schaefer, Georg
    Seifarth, Christof
    Ecker, Simone
    Verdorfer, Irmgard
    Graber, Armin
    Sueltmann, Holger
    Klocker, Helmut
    [J]. PLOS ONE, 2013, 8 (02):
  • [36] The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer
    McArdle, PA
    Canna, K
    McMillan, DC
    McNicol, AM
    Campbell, R
    Underwood, MA
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (03) : 541 - 543
  • [37] Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting
    Miyahira, Andrea K.
    Roychowdhury, Sameek
    Goswami, Sangeeta
    Ippolito, Joseph E.
    Priceman, Saul J.
    Pritchard, Colin C.
    Sfanos, Karen S.
    Subudhi, Sumit K.
    Simons, Jonathan W.
    Pienta, Kenneth J.
    Soule, Howard R.
    [J]. PROSTATE, 2017, 77 (02) : 123 - 144
  • [38] Nakano O, 2001, CANCER RES, V61, P5132
  • [39] Infiltration of CD8+Lymphocytes is an Independent Prognostic Factor of Biochemical Failure-Free Survival in Prostate Cancer
    Ness, Nora
    Andersen, Sigve
    Valkov, Andrej
    Nordby, Yngve
    Donnem, Tom
    Al-Saad, Samer
    Busund, Lill-Tove
    Bremnes, Roy M.
    Richardsen, Elin
    [J]. PROSTATE, 2014, 74 (14) : 1452 - 1461
  • [40] Molecular Subtyping of Primary Prostate Cancer Reveals Specific and Shared Target Genes of Different ETS Rearrangements
    Paulo, Paula
    Ribeiro, Franclim R.
    Santos, Joana
    Mesquita, Diana
    Almeida, Mafalda
    Barros-Silva, Joao D.
    Itkonen, Harri
    Henrique, Rui
    Jeronimo, Carmen
    Sveen, Anita
    Mills, Ian G.
    Skotheim, Rolf I.
    Lothe, Ragnhild A.
    Teixeira, Manuel R.
    [J]. NEOPLASIA, 2012, 14 (07): : 600 - +